AnaptysBio, Inc. (ANAB)

AnaptysBio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	1,803	1,358	403	570	884	961
Market Cap Growth	258.54%	236.68%	-29.18%	-35.53%	-8.03%	63.35%
Enterprise Value	1,782	1,059	32.2	194.84	460.19	432.09
Last Close Price	62.72	48.48	13.24	21.42	30.99	34.75
PE Ratio	-	-105.39	-2.59	-3.52	-6.78	-16.47
Forward PE	-	-	-	-	-	16.86
PS Ratio	7.69	5.79	4.42	33.21	85.90	15.21
PB Ratio	47.23	36.51	5.69	6.47	3.37	2.70
P/TBV Ratio	48.47	37.47	5.30	6.55	3.33	2.67
P/FCF Ratio	91.95	69.27	-2.97	-4.68	-11.95	-20.32
P/OCF Ratio	91.54	68.96	-2.98	-4.72	-12.01	-20.92
EV/Sales Ratio	7.60	4.51	0.35	11.36	44.74	6.84
EV/EBITDA Ratio	36.78	21.85	-0.28	-1.19	-4.02	-7.69
EV/EBIT Ratio	37.21	22.11	-0.28	-1.19	-4.00	-7.61
EV/FCF Ratio	90.88	53.99	-0.24	-1.60	-6.22	-9.14
Debt / Equity Ratio	0.32	0.32	0.20	0.18	0.07	0.05
Debt / EBITDA Ratio	0.17	0.29	-0.14	-0.11	-0.17	-0.37
Debt / FCF Ratio	0.72	0.72	-0.12	-0.15	-0.26	-0.44
Net Debt / Equity Ratio	-8.00	-8.00	-5.21	-4.24	-1.61	-1.48
Net Debt / EBITDA Ratio	-3.58	-6.14	3.23	2.28	3.68	9.38
Net Debt / FCF Ratio	-15.17	-15.17	2.72	3.07	5.70	11.15
Asset Turnover	0.55	0.55	0.19	0.03	0.02	0.12
Quick Ratio	8.94	8.94	9.38	10.62	16.99	34.10
Current Ratio	9.07	9.07	9.51	10.87	17.16	34.40
Return on Equity (ROE)	-24.49%	-24.49%	-182.71%	-93.44%	-41.62%	-15.35%
Return on Assets (ROA)	19.23%	11.15%	-24.56%	-30.94%	-18.37%	-10.72%
Return on Invested Capital (ROIC)	229.21%	132.91%	-284.60%	-192.81%	-102.29%	-135.60%
Return on Capital Employed (ROCE)	21.62%	12.54%	-26.94%	-32.91%	-19.01%	-11.10%
Earnings Yield	-0.73%	-0.95%	-38.67%	-28.38%	-14.75%	-6.07%
FCF Yield	1.09%	1.44%	-33.63%	-21.35%	-8.37%	-4.92%
Buyback Yield / Dilution	4.11%	4.11%	-23.02%	8.34%	-1.34%	-0.27%

Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q